Study programme | Français | ||
GMP-GLP-Validation | |||
Programme component of Master's Degree in Biomedicine à la Faculty of Medicine and Pharmacy |
Code | Type | Head of UE | Department’s contact details | Teacher(s) |
---|---|---|---|---|
UM-M2-BIOMED-001-M | Compulsory UE | DEBAUVE Gaël | M101 - FMP - Service du Doyen |
|
Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
---|---|---|---|---|---|---|---|---|---|
| Français | 15 | 0 | 0 | 0 | 0 | 2.00 | 2.00 |
AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
---|---|---|---|---|---|---|---|---|
M-DOYM-012 | GMP-GLP-Validation | 15 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
Unité d'enseignement |
---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
The objective of this course is to give a clear overview of the main quality standards used in the pharmaceutical industry: current Good Manufacturing Practices (cGMP) and current Good Laboratory Practices (cGLP). We will study the basic principles common to those two quality standards and their specific applications.
Content of UE
Prior Experience
Sans objet
Type of Assessment for UE in Q1
Q1 UE Assessment Comments
Depending of the number of students, the 1st examination session assessment will consist in: A written part (MCQ: 50%) and a oral part (50%): limited number of students A written part (MCQ + open questions: 100%): high number of students
Type of Assessment for UE in Q2
Q2 UE Assessment Comments
Not applicable
Type of Assessment for UE in Q3
Q3 UE Assessment Comments
The 2nd examination session assessment will consist in a written part (MCQ: 50%) and a oral part (50%).
Type of Resit Assessment for UE in Q1 (BAB1)
Q1 UE Resit Assessment Comments (BAB1)
Type of Teaching Activity/Activities
AA | Type of Teaching Activity/Activities |
---|---|
M-DOYM-012 |
|
Mode of delivery
AA | Mode of delivery |
---|---|
M-DOYM-012 |
|
Required Reading
AA | |
---|---|
M-DOYM-012 |
Required Learning Resources/Tools
AA | Required Learning Resources/Tools |
---|---|
M-DOYM-012 | A pdf copy of the Powerpoint slides presented during the lectures will be available for download onto the Moodle platform |
Recommended Reading
AA | |
---|---|
M-DOYM-012 |
Recommended Learning Resources/Tools
AA | Recommended Learning Resources/Tools |
---|---|
M-DOYM-012 | Sans objet |
Other Recommended Reading
AA | Other Recommended Reading |
---|---|
M-DOYM-012 | [1] ICH Q2: Validation of Analytical Procedures: Test and Methodology; CPMP/ICH/381/95 guideline. [2] Guide de Validation des Méthodes en Biologie Médicale;Cofrac, Document LAB GTA04, Révision 00- Juin 2004. [3] Guidance for Industry : Bioanalytical Method Validation;, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001. |
Grade Deferrals of AAs from one year to the next
AA | Grade Deferrals of AAs from one year to the next |
---|---|
M-DOYM-012 | Autorisé |